Galliford Try PLC
11 April 2003
11 April 2003
GALLIFORD TRY PLC
CHANGE IN JOINT VENTURE PARTNER
Galliford Try notes that Wiggins Group plc has today announced that it has sold
its 50% share in its joint venture with Galliford Try to develop the former
Fairfield Hospital site near Letchworth, Bedfordshire to Linden Limited.
David Calverley, Chief Executive of Galliford Try commented:
'We are delighted to welcome a new joint venture partner, especially a quality
developer such as Linden. We have collaborated with Linden on a number of
residential projects, and are currently working with them on a joint development
in Mill Hill. Their acquisition of this interest clearly endorses the potential
of the development.
Having recently secured all the outstanding consents to permit development of
the 44 acre site to proceed, construction of the roads and other infrastructure
works is now commencing, and the first tranches of the site to be sold on to the
contracted housebuilders are expected to complete in the autumn of this year.'
- ends -
For further information:
David Calverley, Chief Executive: 01895 855219
Frank Nelson, Financial Director: 01895 855221
Ann marie Wilkinson/James Chandler
Beattie Financial 020 7398 3300
This information is provided by RNS
The company news service from the London Stock Exchange ESFWSAFSDSESL
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.